Malignant Anal Canal Neoplasm — Trials

Malignant Anal Canal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

23 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 9
Recruiting: 3
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: National Cancer Institute (NCI)
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (3)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01845779	Evaluation of Immune Response Against Human Papillomavirus (HPV)in Patients With Metastatic Cancer of the Anal Canal(Epitopes-HPV01)	completed	N/A	64	Centre Hospitalier Universitaire de BesanconOTHER	1	May 20, 2020	clinicaltrials

Data updated 22 days agoSource updated May 20, 2020source: clinicaltrials